Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 2 EP applications Per Jensen Mikkelsen has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 17, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14710541

ANTIBODIES CAPABLE OF SPECIFICALLY BINDING TWO EPITOPES ON TISSUE FACTOR PATHWAY INHIBITOR

IPC classification:
C07K 16/38, C07K 16/46
Applicant:
Novo Nordisk A/S
Agent:
Per Jensen Mikkelsen, Novo Nordisk A/S
Status:
EXAMINATION REQUESTED
EP15704530

COAGULATION FACTOR IX CONJUGATES

IPC classification:
A61K 47/48, A61P 7/02
Applicant:
Novo Nordisk Health Care AG
Agent:
Witte, Weller & Partner Patentanwälte mbB
Agent:
Per Jensen Mikkelsen, Novo Nordisk A/S
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature